Autologous T cell therapy for PRAME+ advanced solid tumors in HLA-A*02+ patients: a phase 1 trial
2025 · Nature Medicine · 29 citations
https://doi.org/10.1038/s41591-025-03650-6
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
1
Papers
29
Citations
1
h-index
1
i10-index
Dejka M Araurjo is an academic researcher from The University of Texas MD Anderson Cancer Center. The author has contributed to research in topics: Immunotherapy and Immune Responses & Immune Cell Function and Interaction & CAR-T cell therapy research. The author has an h-index of 1, co-authored 1 publications.
Click to start Chat